Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-02 5:16 pm Purchase | 13G | AXCELLA HEALTH INC AXLA | Societe des Produits Nestle S.A. | 11,105,438 15.090% | 6,799,897 (+157.93%) | View |
| 2022-10-19 3:22 pm Purchase | 13G | ChromaDex Corp. CDXC | Societe des Produits Nestle S.A. | 3,816,794 5.110% | 3,816,794 (New Position) | View |
| 2021-02-12 1:52 pm Purchase | 13G | AXCELLA HEALTH INC AXLA | Societe des Produits Nestle S.A. | 4,305,541 11.470% | 4,305,541 (New Position) | View |
| 2020-10-13 10:48 am Sale | 13D | Aimmune Therapeutics Inc. AIMT | Societe des Produits Nestle S.A. | 100 100.000% | -12,813,147 (-100.00%) | View |
| 2020-08-31 06:47 am Purchase | 13D | Aimmune Therapeutics Inc. AIMT | Societe des Produits Nestle S.A. | 12,813,247 19.600% | 12,813,247 (New Position) | View |